Complete Dose Comparison: Your Entire Treatment Journey
Why Complete Dose Availability Matters When Choosing Wegovy or Mounjaro
When deciding whether Wegovy or Mounjaro is better for your weight management goals, having assured access to every dose becomes crucial for long-term success. Wegovy requires a mandatory 17-week dose escalation from 0.25mg through 0.5mg, 1mg, and 1.7mg before reaching the 2.4mg maintenance dose, while Mounjaro follows its own escalation from 2.5mg to 15mg over 12-16 weeks. Many patients experience treatment interruptions when their pharmacy cannot supply the next dose in sequence, potentially compromising their progress and requiring a restart at lower doses. At EverydayMeds, our comprehensive stock levels across both medications ensure seamless progression through your entire treatment journey.
The practical advantage extends beyond mere convenience—consistent dosing schedules are essential for maintaining the appetite suppression and satiety effects that make these treatments effective. Whether your prescriber determines Wegovy's GLP-1 mechanism or Mounjaro's dual-hormone approach is better suited to your clinical profile, you'll have uninterrupted access to every dose strength. Our 'one pharmacy for life' approach means building familiarity with your treatment pattern, storage requirements, and individual response, creating a more personalised experience than constantly switching between suppliers who may not understand your treatment history.
Pricing Comparison: Wegovy vs Mounjaro Across All Dose Strengths
Understanding the complete cost implications helps determine whether Wegovy or Mounjaro offers better value across your treatment timeline. Wegovy pricing at EverydayMeds ranges from £79.99 for the 0.25mg starter dose through £209.99 for the 2.4mg maintenance strength, with discount code FIRST40 applied for new customers and DOSE25 for returning patients at checkout. Our bundle options provide supply security—the Intro Trio (0.25mg, 0.5mg, 1mg) costs £299.99, covering your first 12 weeks, while the Ultimate Stability Trio delivers three months of 2.4mg maintenance supply for £649.99. This transparent pricing structure allows accurate treatment budgeting from week one through long-term maintenance.
Mounjaro pricing follows a different structure reflecting its distinct dosing regimen, with costs varying across the 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg strengths available through our assessment process. The key financial consideration isn't just individual pen costs but total treatment investment over 12+ months, factoring in your prescribed maintenance dose and frequency. Both medications represent significant ongoing expenses, making pharmacy reliability and consistent pricing policies essential—EverydayMeds' stable pricing and bundle discounts provide cost predictability whether your prescriber determines Wegovy or Mounjaro better suits your clinical needs and financial circumstances.
Clinical Evidence: How Wegovy and Mounjaro Compare in Weight Management
The clinical evidence supporting both treatments demonstrates why choosing between Wegovy or Mounjaro requires individualised assessment rather than declaring one universally better. In the STEP 1 trial, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo, while the STEP 5 study showed sustained clinically studied weight loss at 2 years (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial further demonstrated a 20% reduction in major cardiovascular events, highlighting Wegovy's broader health benefits beyond weight management.
Mounjaro's clinical profile stems from its dual GIP and GLP-1 receptor agonism, creating a different mechanism of action compared to Wegovy's pure GLP-1 approach. However, direct comparison of trial weight loss percentages can be misleading due to different study designs, patient populations, and endpoints used across the respective research programmes. Your prescriber will evaluate factors including your BMI, comorbidities, previous treatment responses, and individual tolerability profile to determine whether Wegovy's established mechanism or Mounjaro's dual-hormone approach offers better therapeutic potential for your specific circumstances.
How Wegovy Works: Understanding the GLP-1 Mechanism
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics glucagon-like peptide-1, a natural hormone released by your intestine in response to food intake. This mechanism works by binding to GLP-1 receptors in the brain's appetite control centres, particularly the hypothalamus, reducing hunger signals and creating earlier satiety after smaller meals. The medication also slows gastric emptying, meaning food remains in your stomach longer, prolonging feelings of fullness and reducing the desire to eat between meals. Unlike appetite suppressants that work on different neurotransmitter systems, Wegovy's mechanism closely mirrors your body's natural fullness signalling, potentially explaining its sustained effectiveness in clinical trials. The once-weekly injection schedule maintains consistent GLP-1 receptor activation, providing steady appetite regulation rather than the peaks and troughs associated with daily medications. This mechanism must work alongside a reduced-calorie diet and increased physical activity to achieve the weight management outcomes demonstrated in clinical studies.
Complete Ordering Process: From Assessment to All Dose Delivery
Getting started with either Wegovy or Mounjaro through EverydayMeds begins with our comprehensive 3-minute online clinical assessment, designed to capture the medical history and current health status your prescriber needs to determine which treatment may be more suitable. The assessment covers BMI calculations, weight-related comorbidities, previous weight management attempts, current medications, and any contraindications that might influence whether Wegovy or Mounjaro represents the better choice for your circumstances. Following assessment submission, our UK-qualified prescribers review your information within standard 3 working days, or 24 hours if you select express review, ensuring thorough evaluation rather than rushed decisions. Once approved, your prescribed medication ships via next-day delivery using specialised cold-chain transportation to maintain the 2-8°C storage requirements essential for both treatments. Our GPhC-registered pharmacy (GPhC #9012878) handles every step from clinical review through temperature-controlled dispatch, maintaining the quality and efficacy of these prescription-only medicines throughout the supply chain.
Storage and Practical Considerations: Wegovy vs Mounjaro Convenience
Practical storage differences can influence whether Wegovy or Mounjaro proves better for your lifestyle and travel requirements. Wegovy offers superior storage flexibility, maintaining stability for up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This advantage becomes significant for frequent travellers, shift workers, or anyone whose lifestyle makes consistent refrigeration challenging. Both medications use pre-filled injection pens—Wegovy's FlexTouch system and Mounjaro's equivalent—designed for once-weekly subcutaneous injection into the thigh, abdomen, or upper arm. The dose escalation schedules differ substantially: Wegovy's mandatory 17-week progression (0.25mg→0.5mg→1mg→1.7mg→2.4mg) versus Mounjaro's 12-16 week escalation (2.5mg→5mg→7.5mg→10mg→12.5mg→15mg), affecting how long you'll be adjusting doses before reaching maintenance therapy. Understanding these practical elements helps determine which treatment better fits your routine and preferences alongside the clinical considerations your prescriber evaluates.
Why All Doses Available Matters for Long-Term Success
The availability of complete dose ranges becomes critical when comparing whether Wegovy or Mounjaro offers better long-term outcomes because treatment interruptions significantly impact effectiveness and tolerability. Many patients experience setbacks when their pharmacy cannot supply the next scheduled dose strength, forcing either treatment delays or switches to different suppliers mid-escalation. These disruptions can necessitate restarting at lower doses if gaps exceed manufacturer guidelines, essentially restarting your weight management progress and extending the time to reach therapeutic maintenance doses. At EverydayMeds, our commitment to stocking every dose strength of both medications eliminates these supply-chain risks that plague other providers.
Beyond avoiding interruptions, having all doses available enables more flexible escalation schedules if you experience tolerability issues during dose increases. Some patients require extended periods at intermediate doses (such as Wegovy 1mg or Mounjaro 7.5mg) before progressing further, and our complete inventory supports these individualised adjustments without forcing premature advancement or treatment discontinuation. This flexibility often determines whether patients achieve their long-term weight management goals or abandon treatment due to rigid protocols that don't accommodate individual responses—making comprehensive dose availability a key factor in determining which treatment proves better for your sustained success.
Start Your Complete Treatment Journey Today
Whether clinical assessment determines Wegovy or Mounjaro better suits your weight management goals, EverydayMeds provides the complete infrastructure for long-term success through our comprehensive dose availability and expert clinical support. New customers benefit from discount code FIRST40 applied at checkout, while returning patients use DOSE25 for continued savings across their treatment journey. Our streamlined ordering process, from 3-minute assessment through next-day cold-chain delivery, ensures rapid treatment initiation with ongoing support for the months and years of therapy required for sustained weight management outcomes. Begin your clinical assessment today at https://everydaymeds.co.uk/collections/wegovy to discover which treatment our UK-qualified prescribers recommend for your individual circumstances. Both Wegovy and Mounjaro represent significant advances in weight management medicine, and our complete dose availability ensures your chosen treatment never experiences supply interruptions that could compromise your progress toward healthier outcomes.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
